Nathaniel E. David's most recent trade in Unity Biotechnology Inc was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 21, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Unity Biotechnology Inc | Nathaniel E. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Unity Biotechnology Inc | Nathaniel E. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 6,000 | 6,000 | - | - | Stock Option (Right to Buy) | |
Unity Biotechnology Inc | Nathaniel E. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |